balance equationreview2024-03-30
Difference 2135000 exceeds tolerance 1642952.000. Presentation or filing-vintage differences need review.
Revenue
$670.48M
Fiscal year ended 2026-07-04Operating income
$79.98M
Fiscal year ended 2026-07-04Free cash flow
Unavailable
Fiscal year ended 2026-07-04Aveanna Healthcare Holdings, Inc. (AVAH) reported revenue of $670.48M and net income of $40.29M for the fiscal year ended 2026-07-04. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Aveanna Healthcare Holdings, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Home Health Care Services.
Income
| Metric | 2026-07-04 | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-28 | 2024-06-29 | 2024-03-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $670.48M | $647.92M | $662.48M | $621.94M | $589.55M | $559.22M | $519.87M | $509.02M | $504.96M | $490.65M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | $218.52M | $205.43M | $213.30M | $202.82M | $210.80M | $183.56M | $171.72M | $159.70M | $158.27M | $145.85M |
| Operating income | $79.98M | $69.33M | $71.04M | $53.58M | $80.03M | $51.80M | $45.77M | $34.02M | $37.13M | $22.87M |
| Net income | $40.29M | $41.65M | $178.75M | $14.06M | $27.02M | $5.19M | $29.18M | -$42.84M | $13.91M | -$11.17M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 224.86M | shares 222.10M | Unavailable | shares 222.23M | shares 210.44M | shares 206.24M | Unavailable | shares 193.36M | shares 196.87M | shares 192.24M |
| Pretax income | $56.47M | $44.98M | $39.24M | $13.42M | $44.14M | $10.15M | $26.94M | -$27.33M | $3.98M | $1.49M |
| Income tax expense | $16.18M | $3.32M | -$139.51M | -$647.00K | $17.11M | $4.96M | -$2.24M | $15.51M | -$9.93M | $12.66M |
| Diluted EPS | $0.18 | $0.19 | Unavailable | $0.06 | $0.13 | $0.03 | Unavailable | $-0.22 | $0.07 | $-0.06 |
| Selling, general & administrative | $97.08M | $95.79M | $97.64M | $95.40M | $90.07M | $91.39M | $88.74M | $88.18M | $87.97M | $87.91M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-07-04 | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-28 | 2024-06-29 | 2024-03-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $97.20M | $189.27M | $193.26M | $145.87M | $100.74M | $71.49M | $84.29M | $78.46M | $47.66M | $42.61M |
| Total assets | $2.11B | $2.02B | $2.01B | $1.81B | $1.77B | $1.66B | $1.66B | $1.64B | $1.66B | $1.64B |
| Current assets | $478.09M | $575.30M | $560.23M | $502.60M | $449.92M | $407.62M | $392.67M | $381.37M | $364.00M | $336.04M |
| Total liabilities | $1.82B | $1.78B | $1.82B | $1.80B | $1.78B | $1.76B | $1.79B | $1.80B | $1.78B | $1.78B |
| Current liabilities | $411.32M | $390.43M | $424.46M | $409.69M | $414.23M | $388.31M | $402.17M | $406.04M | $389.15M | $381.93M |
| Total equity incl. NCI | $287.28M | $240.05M | $194.46M | $9.18M | -$11.99M | -$100.13M | -$123.55M | -$156.44M | -$118.97M | -$136.27M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $337.23M | $332.68M | $313.36M | $312.83M | $316.28M | $294.83M | $265.19M | $265.45M | $272.96M | $257.54M |
| Goodwill | $1.28B | $1.12B | $1.12B | $1.12B | $1.12B | $1.05B | $1.05B | $1.05B | $1.05B | $1.05B |
| Long-term debt | $1.28B | $1.28B | $1.29B | $1.29B | $1.27B | $1.27B | $1.27B | $1.28B | $1.27B | $1.28B |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-07-04 | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-28 | 2024-06-29 | 2024-03-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $80.93M | $4.35M | $49.72M | $33.20M | $51.57M | -$8.63M | $13.41M | $29.39M | $1.81M | -$11.97M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$175.37M | -$4.56M | -$1.95M | -$2.02M | -$15.98M | -$2.35M | -$1.53M | -$2.21M | -$1.27M | -$1.31M |
| Financing cash flow | $2.36M | -$3.78M | -$377.00K | $13.95M | -$6.34M | -$1.81M | -$6.05M | $3.62M | $4.51M | $11.94M |
| Net change in cash | -$92.08M | -$3.99M | $47.39M | $45.13M | $29.24M | -$12.79M | $5.83M | $30.80M | $5.05M | -$1.34M |
| Stock-based compensation | $4.14M | $4.15M | $3.95M | $4.96M | $5.16M | $11.00M | $4.98M | $4.90M | $3.50M | $4.08M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $2.85M | $3.04M | $2.73M | $2.60M | $2.62M | $2.59M | $2.45M | $2.59M | $2.83M | $2.91M |
Derived
| Metric | 2026-07-04 | 2026-04-04 | 2026-01-03 | 2025-09-27 | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-28 | 2024-06-29 | 2024-03-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 32.6% | 31.7% | 32.2% | 32.6% | 35.8% | 32.8% | 33.0% | 31.4% | 31.3% | 29.7% |
| Operating margin | 11.9% | 10.7% | 10.7% | 8.6% | 13.6% | 9.3% | 8.8% | 6.7% | 7.4% | 4.7% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 0.6% | 0.6% | 0.6% | 0.8% | 0.9% | 2.0% | 1.0% | 1.0% | 0.7% | 0.8% |
| Current ratio | 1.16x | 1.47x | 1.32x | 1.23x | 1.09x | 1.05x | 0.98x | 0.94x | 0.94x | 0.88x |
| Revenue YoY growth | 13.7% | 15.9% | 27.4% | 22.2% | 16.8% | 14.0% | 8.6% | 6.5% | 7.0% | 5.2% |
| Net margin | 6.0% | 6.4% | 27.0% | 2.3% | 4.6% | 0.9% | 5.6% | -8.4% | 2.8% | -2.3% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 4.47x | Unavailable | 6.62x | 140.39x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 28.7% | 7.4% | -355.5% | -4.8% | 38.8% | 48.8% | -8.3% | Unavailable | -249.5% | 849.8% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AVAH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-19View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Reconciliation checks needing review
7 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2023-12-30
Difference 2135000 exceeds tolerance 1612985.000. Presentation or filing-vintage differences need review.
balance equationreview2023-09-30
Difference 2135000 exceeds tolerance 1654703.000. Presentation or filing-vintage differences need review.
balance equationreview2023-07-01
Difference 2135000 exceeds tolerance 1741402.000. Presentation or filing-vintage differences need review.
balance equationreview2023-04-01
Difference 2135000 exceeds tolerance 1730895.000. Presentation or filing-vintage differences need review.
balance equationreview2022-12-31
Difference 2135000 exceeds tolerance 1711760.000. Presentation or filing-vintage differences need review.
balance equationreview2022-10-01
Difference 2135000 exceeds tolerance 1973369.000. Presentation or filing-vintage differences need review.